Berislav V. Zloković

Berislav V. Zloković's AcademicInfluence.com Rankings

Biology

#3868

World Rank

#5857

Historical Rank

Neuroscience

#381

World Rank

#398

Historical Rank

biology Degrees

Download Badge

Biology

Berislav V. Zloković's Degrees

PhD Biochemistry University of Belgrade
Doctorate Medicine University of Belgrade

Why Is Berislav V. Zloković Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Berislav V. Zloković's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders (2008) (2758)
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders (2011) (2146)
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders (2018) (1329)
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. (2000) (1322)
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus (2015) (1289)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain (2003) (1274)
Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging (2010) (1179)
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A (2012) (993)
Establishment and Dysfunction of the Blood-Brain Barrier (2015) (954)
Blood-Brain Barrier: From Physiology to Disease and Back. (2019) (910)
Neurovascular mechanisms of Alzheimer's neurodegeneration (2005) (897)
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease (2009) (802)
Central nervous system pericytes in health and disease (2011) (790)
The cytoprotective protein C pathway. (2007) (758)
Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction (2018) (758)
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease (2017) (692)
LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms (2004) (681)
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. (2008) (667)
Pericytes of the neurovascular unit: key functions and signaling pathways (2016) (651)
Clearance systems in the brain—implications for Alzheimer disease (2015) (632)
Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System (2007) (626)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. (2005) (595)
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective (2003) (588)
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline (2020) (507)
Pericyte loss influences Alzheimer-like neurodegeneration in mice (2013) (495)
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease (2015) (478)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. (2012) (475)
The role of brain vasculature in neurodegenerative disorders (2018) (473)
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration (2015) (435)
Clearance systems in the brain-implications for Alzheimer disease. (2015) (434)
Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. (1996) (429)
Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease (2009) (427)
LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. (2004) (423)
Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease (2016) (411)
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration (2008) (410)
RAGE (Yin) Versus LRP (Yang) Balance Regulates Alzheimer Amyloid &bgr;-Peptide Clearance Through Transport Across the Blood–Brain Barrier (2004) (399)
Alzheimer’s disease: A matter of blood–brain barrier dysfunction? (2017) (385)
Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy. (2016) (385)
Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's Disease (2013) (380)
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons (2018) (368)
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. (2016) (366)
Vascular dysfunction—The disregarded partner of Alzheimer's disease (2019) (361)
Clearance of amyloid-β by circulating lipoprotein receptors (2007) (356)
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. (2007) (350)
Clearing amyloid through the blood–brain barrier (2004) (348)
Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain (2017) (341)
Central role for PICALM in amyloid–β blood–brain barrier transcytosis and clearance (2015) (327)
Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein Precursor* (2004) (324)
Perivascular spaces in the brain: anatomy, physiology and pathology (2020) (283)
Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease (2005) (276)
Preferential Susceptibility of Brain Tumors to the Antiangiogenic Effects of an &agr;v Integrin Antagonist (2001) (270)
Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling (2010) (264)
Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3 (2004) (264)
Apolipoprotein J (clusterin) and Alzheimer's disease (2000) (256)
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. (2000) (255)
Pericyte degeneration causes white matter dysfunction in the mouse central nervous system (2018) (254)
Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis (2012) (253)
Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. (1998) (248)
Activated protein C inhibits tissue plasminogen activator–induced brain hemorrhage (2006) (248)
SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells (2009) (242)
IgG-Assisted Age-Dependent Clearance of Alzheimer's Amyloid β Peptide by the Blood–Brain Barrier Neonatal Fc Receptor (2005) (238)
Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. (2009) (234)
Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. (2013) (230)
Coupling of Angiogenesis and Neurogenesis in Cultured Endothelial Cells and Neural Progenitor Cells after Stroke (2008) (228)
Clearance of amyloid-beta by circulating lipoprotein receptors. (2007) (220)
Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain (2010) (217)
Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C (2004) (215)
beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. (2000) (205)
The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease? (2014) (203)
Anti-Inflammatory, Antithrombotic, and Neuroprotective Effects of Activated Protein C in a Murine Model of Focal Ischemic Stroke (2001) (203)
Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss (2019) (201)
Activated protein C: biased for translation. (2015) (194)
Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. (2012) (193)
Hypertension Induces Brain &bgr;-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature (2012) (193)
Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype (2007) (192)
Circulating Antibody against Tumor Necrosis Factor–Alpha Protects Rat Brain from Reperfusion Injury (1998) (191)
Blood–spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice (2014) (179)
Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells. (2009) (176)
Neurodegeneration and the neurovascular unit (2010) (174)
Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. (2000) (173)
Understanding the role of the perivascular space in cerebral small vessel disease (2018) (168)
Consensus statement for diagnosis of subcortical small vessel disease (2016) (163)
Blood–spinal cord barrier pericyte reductions contribute to increased capillary permeability (2012) (162)
The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. (2008) (162)
Blood-Brain Barrier Transport of Circulating Alzheimer′s Amyloid β (1993) (158)
Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier. (1996) (155)
Brain imaging of neurovascular dysfunction in Alzheimer’s disease (2016) (154)
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: the role, regulation and restoration of LRP1 (2015) (152)
Measurement of Solute Transport Across the Blood–Brain Barrier in the Perfused Guinea Pig Brain: Method and Application to N‐Methyl‐α‐Aminoisobutyric Acid (1986) (152)
Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. (1994) (150)
Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease. (2012) (150)
Isoform‐Specific Effects of Apolipoproteins E2, E3, and E4 on Cerebral Capillary Sequestration and Blood‐Brain Barrier Transport of Circulating Alzheimer's Amyloid β (1997) (147)
Two‐Photon Imaging of Astrocytic Ca2+ Signaling and the Microvasculature in Experimental Mice Models of Alzheimer's Disease (2007) (142)
Cerebrovascular Accumulation and Increased Blood‐Brain Barrier Permeability to Circulating Alzheimer's Amyloid β Peptide in Aged Squirrel Monkey with Cerebral Amyloid Angiopathy (1998) (139)
New therapeutic targets in the neurovascular pathway in Alzheimer’s disease (2008) (138)
Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. (2002) (135)
Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis (2012) (131)
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism (2018) (129)
Cytoprotective protein C pathways and implications for stroke and neurological disorders (2011) (129)
Permeability of the Blood‐Brain Barrier to the Immunosuppressive Cyclic Peptide Cyclosporin A (1990) (129)
Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. (1999) (127)
Clearance of amyloid β-peptide from brain: transport or metabolism? (2000) (126)
Transport of Leucine‐Enkephalin Across the Blood‐Brain Barrier in the Perfused Guinea Pig Brain (1987) (121)
Chronic Nicotine Treatment Enhances Focal Ischemic Brain Injury and Depletes Free Pool of Brain Microvascular Tissue Plasminogen Activator in Rats (1997) (120)
Myocardin Is Sufficient for a Smooth Muscle–Like Contractile Phenotype (2008) (119)
A simple method for isolation and characterization of mouse brain microvascular endothelial cells (2003) (118)
Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1. (2003) (116)
Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part II: Vector Systems and Delivery Methodologies for Gene Therapy of the Central Nervous System. (1997) (114)
Protein C anticoagulant and cytoprotective pathways (2012) (113)
Blood-brain barrier permeability to leucine-enkephalin,d-Alanine2-d-leucine5-enkephalin and their N-terminal amino acid (tyrosine) (1985) (111)
Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. (2010) (108)
Substitution at codon 22 reduces clearance of Alzheimer’s amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood (2002) (106)
Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin‐bound and free iron into the rat brain (2004) (105)
Differential expression of Na,K-ATPase alpha and beta subunit isoforms at the blood-brain barrier and the choroid plexus. (1993) (103)
Neurovascular Pathways and Alzheimer Amyloid β‐peptide (2005) (103)
Kinetics of arginine-vasopressin uptake at the blood-brain barrier. (1990) (100)
Activated Protein C Promotes Neovascularization and Neurogenesis in Postischemic Brain via Protease-Activated Receptor 1 (2008) (98)
Cerebrovascular Permeability to Peptides: Manipulations of Transport Systems at the Blood-Brain Barrier (1995) (96)
Recommendations of the Alzheimer's Disease–Related Dementias Conference (2014) (95)
Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities. (2012) (95)
Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. (2002) (93)
Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone (1985) (91)
Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown. (2013) (91)
Functional and structural properties of lipid-associated apolipoprotein J (clusterin). (1999) (90)
Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity (2009) (90)
Brain Clearance of Alzheimer's Amyloid-β40 in the Squirrel Monkey: A SPECT Study in a Primate Model of Cerebral Amyloid Angiopathy (2002) (89)
Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood–brain barrier permeability using dynamic contrast‐enhanced MRI (2016) (88)
Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease (2015) (86)
Kinetic Analysis of Leucine‐Enkephalin Cellular Uptake at the Luminal Side of the Blood‐Brain Barrier of an In Situ Perfused Guinea‐Pig Brain (1989) (85)
Shedding of soluble platelet-derived growth factor receptor-β from human brain pericytes (2015) (85)
Activated protein C, protease activated receptor 1, and neuroprotection. (2018) (84)
Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon. (1985) (82)
Slow Penetration of Thyrotropin‐Releasing Hormone Across the Blood‐Brain Barrier of an In Situ Perfused Guinea Pig Brain (1988) (81)
Protein S Confers Neuronal Protection During Ischemic/Hypoxic Injury in Mice (2003) (81)
The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease. (2002) (80)
Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model. (2003) (79)
Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs (1996) (79)
Glycoprotein 330/Megalin (LRP-2) Has Low Prevalence as mRNA and Protein in Brain Microvessels and Choroid Plexus (1999) (76)
Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling (2017) (74)
Blood-Brain Barrier Permeability and Gadolinium: Benefits and Potential Pitfalls in Research. (2016) (73)
Evidence for the Existence of a Sodium-dependent Glutathione (GSH) Transporter (1996) (70)
Functional recovery after embolic stroke in rodents by activated protein C (2005) (70)
Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop (2020) (70)
3K3A–activated protein C stimulates postischemic neuronal repair by human neural stem cells in mice (2016) (69)
An Activated Protein C Analog With Reduced Anticoagulant Activity Extends the Therapeutic Window of Tissue Plasminogen Activator for Ischemic Stroke in Rodents (2012) (69)
Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytes. (2004) (68)
Endothelial Protein C Receptor-Assisted Transport of Activated Protein C across the Mouse Blood—Brain Barrier (2009) (67)
Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures (2001) (65)
Role of clusterin in the brain vascular clearance of amyloid-β (2017) (65)
A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig (1990) (64)
Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide. (2000) (64)
Blood-brain barrier transport of circulating Alzheimer's amyloid beta. (1993) (63)
Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain. (1994) (63)
Clearance of amyloid beta-peptide from brain: transport or metabolism? (2000) (62)
Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease. (2011) (61)
PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke. (2018) (61)
Activated Protein C is Neuroprotective and Mediates New Blood Vessel Formation and Neurogenesis After Controlled Cortical Impact (2010) (61)
Cellular and Molecular Neurosurgery: Pathways from Concept to Reality-Part I: Target Disorders and Concept Approaches to Gene Therapy of the Central Nervous System. (1997) (61)
Differential neuroprotection and risk for bleeding from activated protein C with varying degrees of anticoagulant activity. (2009) (60)
Vascular disorder in Alzheimer's disease: role in pathogenesis of dementia and therapeutic targets. (2002) (60)
A single-cell atlas of the normal and malformed human brain vasculature (2022) (59)
Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9 (2014) (59)
Kinetics and Na independence of amino acid uptake by blood side of perfused sheep choroid plexus. (1990) (58)
Remodeling after stroke (2006) (58)
Method for measurement of the blood–brain barrier permeability in the perfused mouse brain: application to amyloid-β peptide in wild type and Alzheimer’s Tg2576 mice (2004) (57)
“Small Blood Vessels: Big Health Problems?”: Scientific Recommendations of the National Institutes of Health Workshop (2016) (57)
ROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies (2015) (57)
Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means (1998) (56)
Protein S Protects Neurons from Excitotoxic Injury by Activating the TAM Receptor Tyro3–Phosphatidylinositol 3-Kinase–Akt Pathway through Its Sex Hormone-Binding Globulin-Like Region (2010) (56)
Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. (2012) (55)
Activated Protein C Analog Protects From Ischemic Stroke and Extends the Therapeutic Window of Tissue-Type Plasminogen Activator in Aged Female Mice and Hypertensive Rats (2013) (55)
An Activated Protein C Analog Stimulates Neuronal Production by Human Neural Progenitor Cells via a PAR1-PAR3-S1PR1-Akt Pathway (2013) (54)
Expression of tissue plasminogen activator in cerebral capillaries: possible fibrinolytic function of the blood-brain barrier. (1995) (54)
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial (2020) (53)
Experimental chronic cerebral hypoperfusion results in decreased pericyte coverage and increased blood–brain barrier permeability in the corpus callosum (2015) (53)
Cranial Suture Regeneration Mitigates Skull and Neurocognitive Defects in Craniosynostosis (2021) (52)
Methamphetamine causes sustained depression in cerebral blood flow (2011) (52)
The promise of protein C. (2006) (51)
Cytoprotective-selective activated protein C therapy for ischaemic stroke (2014) (51)
Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein. (1998) (49)
Brain capillary tissue plasminogen activator in a diabetes stroke model. (1996) (49)
Strategies to circumvent vascular barriers of the central nervous system. (1998) (48)
Remote control of BBB: A tale of exosomes and microRNA (2017) (46)
Activated protein C and ischemic stroke (2004) (45)
Clearance of interstitial fluid (ISF) and CSF (CLIC) group—part of Vascular Professional Interest Area (PIA) (2020) (45)
Channelrhodopsin Excitation Contracts Brain Pericytes and Reduces Blood Flow in the Aging Mouse Brain in vivo (2020) (44)
APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β (2021) (44)
Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice (2010) (43)
Transport of circulating reduced glutathione at the basolateral side of the anterior lens epithelium: physiologic importance and manipulations. (1996) (42)
3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice (2019) (42)
In vivo imaging and analysis of cerebrovascular hemodynamic responses and tissue oxygenation in the mouse brain (2018) (41)
Acute Ablation of Cortical Pericytes Leads to Rapid Neurovascular Uncoupling (2020) (41)
Transport, uptake, and metabolism of blood-borne vasopressin by the blood-brain barrier (1992) (41)
Neutral amino acid uptake by the isolated perfused sheep choroid plexus. (1989) (40)
Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A (2021) (39)
Blood-brain barrier permeability to dipeptides and their constituent amino acids (1983) (39)
Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid (2020) (39)
Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. (1998) (39)
A Lipoprotein Receptor Cluster IV Mutant Preferentially Binds Amyloid-β and Regulates Its Clearance from the Mouse Brain* (2013) (38)
Can Blood–Brain Barrier Play a Role in the Development of Cerebral Amyloidosis and Alzheimer's Disease Pathology (1997) (38)
Thrombomodulin expression in bovine brain capillaries. Anticoagulant function of the blood-brain barrier, regional differences, and regulatory mechanisms. (1997) (37)
Endovascular Restorative Neurosurgery: A Novel Concept for Molecular and Cellular Therapy of the Nervous System (2003) (36)
Activated protein C analog with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact (2010) (36)
Molecular characterization of a reduced glutathione transporter in the lens. (1995) (36)
Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model. (1997) (36)
Cereport™ (RMP-7) Increases the Permeability of Human Brain Microvascular Endothelial Cell Monolayers1 (1999) (34)
Saturable mechanism for delta sleep-inducing peptide (DSIP) at the blood-brain barrier of the vascularly perfused guinea pig brain (1989) (34)
The Blood-Brain Barrier, Amino Acids and Peptides (1990) (34)
Identification of a novel, sodium-dependent, reduced glutathione transporter in the rat lens epithelium. (1996) (34)
TRIM9-Mediated Resolution of Neuroinflammation Confers Neuroprotectionupon Ischemic Stroke in Mice (2019) (34)
Blood-Brain Barrier: A Dual Life of MFSD2A? (2014) (33)
A simple technique to determine glutathione (GSH) levels and synthesis in ocular tissues as GSH-bimane adduct: application to normal and galactosemic guinea-pigs. (1993) (32)
Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol (2018) (32)
The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier A β Clearance in Alzheimer’s Disease (2010) (31)
Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway (2011) (31)
A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid (2020) (31)
Species‐dependent neuroprotection by activated protein C mutants with reduced anticoagulant activity (2009) (31)
Unidirectional uptake of enkephalins at the blood-tissue interface of the blood-cerebrospinal fluid barrier: a saturable mechanism (1988) (31)
An Introduction to the Blood-Brain Barrier (1992) (31)
Hypertension & Cognitive Impairment Hypertension Induces Brain -Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature (2012) (30)
Metaphit, an isothiocyanate analog of PCP, induces audiogenic seizures in mice. (1989) (29)
Vascular plasticity and cognition during normal aging and dementia. (2015) (29)
Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons. (2019) (29)
Pericyte constriction after stroke: the jury is still out (2010) (29)
Nicotine Downregulates α2 Isoform of Na,K-ATPase at the Blood-Brain Barrier and Brain in Rats (1994) (29)
Activated protein C analog promotes neurogenesis and improves neurological outcome after focal ischemic stroke in mice via protease activated receptor 1 (2013) (28)
Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline (2020) (28)
Passage of delta sleep-inducing peptide (DSIP) across the blood-cerebrospinal fluid barrier (1988) (28)
Erratum: Clearance systems in the brain—implications for Alzheimer diseaser (2016) (28)
Circulating neuroactive peptides and the blood-brain and blood-cerebrospinal fluid barriers. (1990) (28)
Mitigating Antagonism between Transcription and Proliferation Allows Near-Deterministic Cellular Reprogramming. (2019) (27)
Electroencephalographic Characteristics of Audiogenic Seizures Induced in Metaphit‐Treated Small Rodents (1991) (27)
Mechanism of amyloid peptide induced CCR5 expression in monocytes and its inhibition by siRNA for Egr-1. (2005) (27)
Exogenous microglia enter the brain and migrate into ischaemic hippocampal lesions (1999) (27)
2016 Scientific Sessions Sol Sherry Distinguished Lecturer in Thrombosis: Thrombotic Stroke: Neuroprotective Therapy by Recombinant-Activated Protein C. (2016) (27)
Neuropeptide transport mechanisms in the central nervous system (1988) (27)
Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system. (1997) (26)
Immunohistochemical localization of tissue plasminogen activator in vascular endothelium of stroke-prone regions of the rat brain. (1998) (26)
Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs. (1996) (26)
Activated protein C promotes neuroprotection: mechanisms and translation to the clinic. (2016) (25)
From the liver to the blood–brain barrier: An interconnected system regulating brain amyloid‐β levels (2011) (24)
Cellular uptake and transport of methylprednisolone at the blood-brain barrier. (1996) (24)
Comparison Between Blood-Brain Barrier Water Exchange Rate and Permeability to Gadolinium-Based Contrast Agent in an Elderly Cohort (2020) (24)
Transport-Clearance Hypothesis for Alzheimer's Disease and Potential Therapeutic Implications (2013) (24)
Endothelial cell protein C receptor: role beyond endothelium? (2007) (23)
Lack of Smad or Notch leads to a fatal game of brain pericyte hopscotch. (2011) (23)
Brain Injury and Cerebrovascular Fibrin Deposition Correlate with Reduced Antithrombotic Brain Capillary Functions in a Hypertensive Stroke Model (2000) (22)
Species-specific anticoagulant and mitogenic activities of murine protein S (2009) (21)
Blood-to-lens transport of reduced glutathione in an in situ perfused guinea-pig eye. (1994) (21)
Antithrombotic, procoagulant, and fibrinolytic mechanisms in cerebral circulation: implications for brain injury and protection. (1997) (21)
A lymphatic waste-disposal system implicated in Alzheimer’s disease (2018) (21)
Kinetics of circulating vasopressin uptake by choroid plexus. (1991) (21)
In vivo approaches for studying peptide interactions at the blood — brain barrier (1990) (20)
Combined neurothrombectomy or thrombolysis with adjunctive delivery of 3K3A-activated protein C in acute ischemic stroke (2015) (20)
Chronic amphetamine intoxication and the blood-brain barrier permeability to inert polar molecules studied in the vascularly perfused guinea pig brain (1989) (19)
Blood–brain barrier link to human cognitive impairment and Alzheimer’s disease (2022) (19)
Every-other-day feeding exacerbates inflammation and neuronal deficits in 5XFAD mouse model of Alzheimer's disease (2020) (18)
Permeability imaging as a predictor of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage (2018) (18)
Metaphit‐Induced Audiogenic Seizures in Mice: II. Studies on N‐Methyl‐d‐Aspartic Acid, GABA, and Sodium Channel Receptors and on the Disposition of Metaphit in the Brain (1993) (17)
Metaphit‐Induced Audiogenic Seizures in Mice: I. Pharmacologic Characterization (1993) (17)
Galactose-induced cataract formation in guinea pigs: morphologic changes and accumulation of galactitol. (1994) (17)
Lower cognitive performance of older football players possessing apolipoprotein E epsilon4. (2001) (17)
Undetectable gadolinium brain retention in individuals with an age-dependent blood-brain barrier breakdown in the hippocampus and mild cognitive impairment (2019) (16)
Functional connectivity among brain regions affected in Alzheimer’s disease is associated with CSF TNF-α in APOE4 carriers (2019) (16)
Small molecule inhibition of PIKFYVE kinase rescues gain- and loss-of-function C9ORF72 ALS/FTD disease processes in vivo (2019) (16)
Role of A β Transport and Clearance in the Pathogenesis and Treatment of Alzheimer’s Disease (2007) (16)
A Review of Translational Magnetic Resonance Imaging in Human and Rodent Experimental Models of Small Vessel Disease (2020) (15)
Can adjunctive therapies augment the efficacy of endovascular thrombolysis? A potential role for activated protein C (2017) (15)
NIH workshop report on the trans-agency blood–brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface (2017) (15)
Microglia have a grip on brain microvasculature (2021) (15)
Short-term fish oil supplementation applied in presymptomatic stage of Alzheimer's disease enhances microglial/macrophage barrier and prevents neuritic dystrophy in parietal cortex of 5xFAD mouse model (2019) (14)
Pericyte constriction underlies capillary de-recruitment during hyperemia in the setting of arterial stenosis. (2019) (13)
Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto. (2019) (13)
Nicotine downregulates alpha 2 isoform of Na,K-ATPase at the blood-brain barrier and brain in rats. (1994) (13)
RMP-7, a bradykinin agonist, increases permeability of blood-ocular barriers in the guinea pig. (1995) (13)
Corneal transport of circulating glutathione in normal and galactosemic guinea pigs. (1999) (13)
Transport of Dopamine at the Blood-Brain Barrier of the Guinea Pig: Inhibition by Psychotropic Drugs and Nicotine (1996) (12)
Neuroactive peptides and amino acids at the blood-brain barrier: possible implications for drug abuse. (1992) (12)
APOE4 Accelerates Development of Dementia After Stroke: Is There a Role for Cerebrovascular Dysfunction? (2020) (12)
Blood-Brain Barrier: A Dual Life of MFSD2A? (2014) (12)
An in situ perfused guinea-pig eye model for blood-ocular transport studies: application to amino acids. (1992) (11)
Low de novo glutathione synthesis from circulating sulfur amino acids in the lens epithelium. (1997) (11)
Neurotoxicity of the anticoagulant-selective E149A-activated protein C variant after focal ischemic stroke in mice. (2013) (11)
Differential Expression of Na , K-ATPase a ! and @ Subunit Isoforms at the Blood-Brain Barrier and the Choroid Plexus * (2001) (10)
Air Pollution Particulate Matter Exposure and Chronic Cerebral Hypoperfusion and Measures of White Matter Injury in a Murine Model (2021) (10)
Haemostatic Functions of the Blood-Brain Barrier: Possible Implications in the Pathogenesis of Stroke (1995) (10)
Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction (2019) (10)
7T multi-shell hybrid diffusion imaging (HYDI) for mapping brain connectivity in mice (2015) (10)
Blood-brain barrier permeability changes during acute allergic encephalomyelitis induced in the guinea pig (1989) (10)
Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen (2021) (9)
Prenatal disruption of blood–brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation (2022) (9)
The small HDL particle hypothesis of Alzheimer's disease (2022) (8)
Influence of the 3K3A‐activated protein C variant on the plasma clot lysis activity of t‐PA and of t‐PA on the variant's anticoagulant activity (2013) (8)
Retroviral vector-mediated transfer and expression of human tissue plasminogen activator cDNA in bovine brain endothelial cells. (1999) (7)
Liver and lens glutathione and cysteine regulation in galactose-fed guinea pigs. (1997) (7)
The effects of aluminum chloride on the rate of secretion of the cerebrospinal fluid (1987) (7)
Imaging subtle leaks in the blood–brain barrier in the aging human brain: potential pitfalls, challenges, and possible solutions (2022) (7)
Therapeutic TVs for Crossing Barriers in the Brain (2020) (7)
Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults (2021) (7)
Rat brain capillary thrombomodulin: structure and function. (1998) (6)
Protection of ischemic white matter and oligodendrocytes in mice by 3K3A-activated protein C (2021) (6)
Brain barriers and their potential role in migraine pathophysiology (2022) (6)
Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation (2021) (6)
FOUR-YEAR LONGITUDINAL STUDY OF COGNITIVELY HEALTHY INDIVIDUALS: CSF AMYLOID/TAU LEVELS AND NANOPARTICLE MEMBRANES IDENTIFY HIGH RISK FOR ALZHEIMER’S DISEASE (2019) (6)
Blood–Brain Barrier Transport of Alzheimer’s Amyloid β-Peptide (2016) (6)
The effects of (R) alpha-methyl histamine on the isolated guinea pig aorta. (1991) (6)
Amino acid transport by a glial blood-brain barrier: studies in an elasmobranch fish (1988) (5)
Activated Protein C Analog With Reduced Anti-Coagulant Activity Improves Functional Recovery and Reduces Bleeding Risk Following Controlled Cortical Impact (2010) (5)
Measurement of thrombomodulin mRNA expression in brain capillaries by polymerase chain reaction. (1998) (5)
The blood-brain barrier in vitro: recent progress (1993) (5)
Prion Protein Antagonists Rescue Alzheimer's Amyloid-β-Related Cognitive Deficits. (2019) (5)
Investigating the blood–spinal cord barrier in preclinical models: a systematic review of in vivo imaging techniques (2021) (5)
Immunoneurology: a serum protein afferent limb to the CNS. (1990) (5)
History and Basic Concepts (1993) (5)
Vasopressin uptake by hypothalamopituitary axis and pineal gland in guinea pigs. (1991) (5)
Amino acids and the blood-brain barrier (1990) (4)
Expression of Na,K-ATPase at the blood-brain interface. (1993) (4)
Experimental psychosis and transport of amino acids and peptides across the blood-brain barrier (1988) (4)
Air Pollution Particulate Matter Amplifies White Matter Vascular Pathology and Demyelination Caused by Hypoperfusion (2021) (4)
Survival and Toxicity of an Allogeneic Cytokine-secreting Fibroblast Vaccine in the Central Nervous System (1998) (4)
Neurovascular and Immuno-Imaging: From Mechanisms to Therapies. Proceedings of the Inaugural Symposium (2016) (3)
Differential brain penetration of cerebroprotective drugs. (1993) (3)
Intravenous Infusion of RMP-7 Increases Ocular Uptake of Ganciclovir (2004) (3)
Current treatments and therapeutic targets in Alzheimer's disease. (2002) (3)
Techniques for the study of the blood-brain barrier in non-mammalian species (1988) (3)
A “multi-omics” analysis of blood–brain barrier and synaptic dysfunction in APOE4 mice (2022) (3)
Slow penetration of [3H] tiazofurin into guinea pig brain by a saturable mechanism. (1995) (3)
Decreased glucose transporter 1 expression at the blood-brain barrier exacerbates Alzheimer disease-like phenotypes in mouse models (2017) (3)
How the brain regulates its own immune system (2022) (3)
3K3A-Activated Protein C Protects the Blood-Brain Barrier and Neurons From Accelerated Ischemic Injury Caused by Pericyte Deficiency in Mice (2022) (3)
Transport of apolipoproteins E and J at the blood-brain barrier. Relevance to Alzheimer's disease (1997) (3)
Effects of sensory-motor cortical lesions on blood-brain permeability in guinea pigs (1989) (3)
Role of the Blood—Brain Barrier in Immunopathogenesis of Experimentally Induced Autoimmune Demyelination (1992) (3)
Characterization of perivascular space pathology in a rat model of cerebral small vessel disease by in vivo magnetic resonance imaging (2022) (3)
Microhemorrhages: Undetectable but clinically meaningful the question persists (2011) (3)
Transport of large peptides and proteins across the blood-brain barrier (1990) (3)
Comparison between blood and saline perfusion on the uptake of amino acids by choroid plexus of the sheep. (1990) (2)
Blood–Brain Barrier and Neurovascular Mechanisms of Neurodegeneration and Injury (2009) (2)
Endothelial Tip Cell Finds Its Way with Piezo1 (2020) (2)
Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier (2023) (2)
In this important study, the authors have provided additional evidence in support of the concept that iNOS (1998) (2)
Targeted cytotoxic gene delivery to malignant gliomas via the fibroblast growth factor receptor (2000) (2)
Carrier-Mediated GSH Transport at the Blood–Brain Barrier and Molecular Characterization of Novel Brain GSH Transporters (2018) (2)
A gliovascular idea for the white matter repair? (2013) (2)
BLOOD-BRAIN BARRIER DAMAGE, NEURONAL DYSFUNCTION, AND DEGENERATION (2014) (2)
NICARDIPINE ATTENUATES FOCAL ISCHEMIC BRAIN INJURY IN RATS (1996) (2)
Neural Stem and Progenitor Cells: A Strategy for Gene Therapy and Brain Repair (1998) (2)
PIKFYVE inhibition mitigates disease in models of diverse forms of ALS (2023) (1)
Transport of Glucose and Amino Acids in the Central Nervous System (1993) (1)
Reply to: Rethink the classical view of cerebrospinal fluid production (2021) (1)
Neuroprotective effects of nicardipine in a rat model of ischemia and reperfusion (1997) (1)
Peptides and Proteins (1993) (1)
Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline (2020) (1)
Review Article Vascular contributions to cognitive impairment and dementia including Alzheimer's disease (2014) (1)
Blood—Brain Barrier Permeability to Peptides and Proteins (1992) (1)
Penetration of [3H] Tiazofurin Into Guinea Pig Eye by a Saturable Mechanism (1995) (1)
Uptake of Thiamine by the Isolated Perfused Sheep Choroid Plexus (1992) (1)
Blood-brain transport of vasopressin. (1993) (1)
Building vascular roadmaps: A novel toolset for visualizing and annotating whole mouse brain vasculature (2020) (1)
Blood-brain barrier mechanisms of neurodegeneration in Alzheimer’s disease (2015) (1)
Treatment of Brain Edema with a Nonpeptide Arginine Vasopressin V1 Receptor Antagonist OPC-21268 in Rats (1999) (1)
Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins (2000) (1)
Can prehospital “plasma supplement” neutralize the systemic storm in severe trauma? (2021) (1)
Factors that influence the concentrations of amino acids in cerebrospinal fluid (1988) (1)
Author Correction: APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β (2021) (1)
Thrombotic Stroke : Neuroprotective Therapy by Recombinant-Activated Protein C (2016) (1)
Neuron-like function of the nephron central command (2021) (1)
Balancing dynamic tradeoffs drives cellular reprogramming (2018) (1)
Reconstruction of major fibers using 7T multi-shell Hybrid Diffusion Imaging in mice (2015) (1)
582 In vivo blood-brain barrier uptake of Alzheimer's Aβ peptides in guinea pigs: Evidence for vascular sequestration of Aβ1-40 (but not Aβ1-42) (1996) (0)
INCREASED CSF MATRIX METALLOPROTEINASE-9 (MMP-9) AND REDUCED WHITE MATTER INTEGRITY IN HEALTHY ELDERLY (2014) (0)
The blood-brain barrier: Cellular and molecular biology Edited by William M. Pardridge. ISBN 0-7817-0015-9. Published by Raven Press, New York. 1993. pp. 476. $98.10 (1995) (0)
Brain peptides and peptidergic pathways (1990) (0)
NIH workshop report on the trans-agency blood–brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface (2017) (0)
Immunological and other aspects of the blood—brain barrier (1990) (0)
O2-03-03 Inefficient LRP-mediated Aβ clearance at the blood-brain barrier contributes to neurotoxic and vasculotropic Aβ brain accumulations (2004) (0)
From the editors (2011) (0)
CLINICAL IMPLICATIONS OF BASIC NEUROSCIENCE RESEARCH (2016) (0)
INTERACTIONS OF VASCULAR AND ALZHEIMER DISEASE (2016) (0)
Epileptogenic Activity of Metaphitinduced Audiogenic Seizure in Small Rodents (1992) (0)
S1-02-06 Clearance of Aβ (2006) (0)
Acetylated tau: A missing link between head injury and dementia. (2021) (0)
CSF SPDGFRB, A MEASURE OF VASCULAR DYSFUNCTION, IS RELATED TO DISRUPTED FUNCTIONAL CONNECTIVITY AMONG BRAIN REGIONS ASSOCIATED WITH ALZHEIMER’S DISEASE (2018) (0)
P4-412 FC and non-FC dependent blood-brain barrier (BBB) clearance from brain to blood of anti-Aβ antibody in mice (2004) (0)
Editorial for “MRI‐Based Investigation of Association Between Cerebrovascular Structural Alteration and White Matter Hyperintensity Induced by High Blood Pressure” (2021) (0)
BIOLOGICAL UNDERPINNINGS OF VASCULAR CONTRIBUTIONS TO DEMENTIA (2016) (0)
ASSOCIATIONS BETWEEN CEREBRAL BLOOD FLOW AND AMYLOID AND TAU PET BINDING IN AD-SPECIFIC REGIONS: FINDINGS FROM 2 INDEPENDENT COHORTS (2019) (0)
P3-207 Activated protein protects neurons against Aβ (N-42, N-40) oligomers neurotoxicity (2004) (0)
Altered Permeability Of The Blood‐CSF Barrier In Chronic Migraine (2018) (0)
Glutathione synthesis from circulating sulfur amino acids is a minor source for the lens epithelial glutathione (1996) (0)
CEREBROSPINAL FLUID MEASURES OF BLOOD BRAIN BARRIER INTEGRITY IN PSEN1-RELATED ALZHEIMER’S DISEASE (2017) (0)
Decreased functional connectivity is associated with increased levels of Cerebral Spinal Fluid soluble-PDGFRβ, a marker of blood brain barrier breakdown, in older adults (2023) (0)
CSF INTERLEUKIN-8, A KEY SIGNALING FACTOR FOR INFLAMMATION, IS ASSOCIATED WITH FUNCTIONAL CONNECTIVITY AND EXECUTIVE FUNCTION (2019) (0)
CSF SPDGFRB, A MEASURE OF VASCULAR DYSFUNCTION, IS RELATED TO DISRUPTED FUNCTIONAL CONNECTIVITY AMONG BRAIN REGIONS ASSOCIATED WITH ALZHEIMER’S DISEASE (2018) (0)
MOLECULAR AND CELL BIOLOGY: ABETA/AMYLOID O3-01-01 INTERACTION BETWEEN OBESITY, BRAIN HDL, AND APOE4 GENOTYPE IN CEREBRAL AMYLOIDOSIS CHRONIC BEHAVIORAL AND NEUROPATHOLOGICAL PHENOTYPES IN WILD-TYPE AND APP/PS1 MICE (2019) (0)
Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias (2022) (0)
New Insights Into the Blood-Brain Barrier (2015) (0)
Glucagon effect on myocardial transport and utilization of energy-metabolites from the coronary microcirculation in the perfused rabbit heart. (1988) (0)
Correction: Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier (2023) (0)
APOE4 blood‐brain barrier dysfunction: relation to cognitive impairment and molecular mechanisms (2022) (0)
UPREGULATION OF ENDOTHELIAL PICALM EXPRESSION USING AN FDA-APPROVED DRUG REDUCES AMYLOID-β LOAD IN THE MURINE BRAIN (2019) (0)
Characterization of spastic paraplegia in a family with a novel PSEN1 mutation (2023) (0)
The relationship between blood‐brain barrier permeability and cerebral blood flow in cognitive impairment (2021) (0)
S4-02-05: Blood-brain barrier mechanisms in Alzheimer's disease: Roles of rage and LRP (2008) (0)
Relationships between cerebrovascular health and tau PET uptake are associated with global cognition (2020) (0)
Urine dicarboxylic acids are metabolic biomarkers of early Alzheimer’s disease (2021) (0)
Novel R41Q- and R46Q-PAR1-Modified Mice Enable Proof-of-Concept Studies for In Vivo Protective Mechanisms of Action for Activated Protein C (APC) in Sepsis and Stroke (2016) (0)
Correction: Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism (2022) (0)
Neurodegeneration and the Brain Barriers Contributors (2007) (0)
O1-03-05 APOE isoform-specific inhibition of angiogenic transduction signaling pathways in human brain endothelium is regulated via LRP and megalin (2004) (0)
The role of peptides in the brain (1990) (0)
The regional relationship between CSF VEGF and white matter microstructural integrity in older adults: A voxelwise DTI study (2022) (0)
Functional hyperconnectivity is associated with higher levels of sPDGFRβ, a marker of blood brain barrier breakdown, in older adults (2022) (0)
Author Correction: Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. (2023) (0)
P3-327 Drug target gene candidates for AD microvascular cells validated using laser capture microdissection (2004) (0)
Strategies for peptide delivery to the brain (1990) (0)
Abstract P750: 3K3A-APC Restores Oligodendrocyte Pools in Models of White Matter Stroke via PAR1 Signaling (2021) (0)
MRI Studies Reporting Summary (2017) (0)
THE BLOOD·BRAIN INTERFACE (1993) (0)
Abstract WP139: MRI Evaluation and Functional Assessment of Brain Injury Improvement After 3K3A-Activated Protein C Treatment for Murine White Matter Stroke (2019) (0)
Abstract WP134: 3K3A-APC Protects Pericyte-deficient Mice From Ischemic Brain Injury (2020) (0)
ALZHEIMER’S DISEASE: A MATTER OF BLOOD-BRAIN BARRIER DYSFUNCTION? (2018) (0)
The role of brain vasculature in neurodegenerative disorders (2018) (0)
The interaction of small peptides with the various cellular interfaces of the blood-brain barrier (1990) (0)
METABOLIC SYNDROME AND DEFAULT MODE NETWORK RSFMRI CONNECTIVITY IN THE HIPPOCAMPUS (2019) (0)
ALZHEIMER’S DISEASE Advances in Genetics, Molecular and Cellular Biology ALZHEIMER’S DISEASE Advances in Genetics, Molecular and Cellular Biology (2013) (0)
Microglial activation: A process potentially related to Alzheimer's disease and late‐life major depression (2020) (0)
Cerebrovascular Biology and the Various Neural Barriers: Challenges and Future Directions (1999) (0)
Addition of Elemental Iodine to Surgical Irrigation for Shunt Infection Prophylaxis (1999) (0)
BRAIN IMAGING OF VASCULAR DYSFUNCTION AS AN EARLY BIOMARKER OF COGNITIVE DECLINE (2019) (0)
Edinburgh Research Explorer A Review of Translational Magnetic Resonance Imaging in Human and Rodent Experimental Models of Small Vessel Disease (2020) (0)
The liver and muscle secreted Hfe2-protein maintains blood brain barrier integrity (2021) (0)
CEREBRAL PROTECTION FROM THE LAZAROID DES-METHYLTIRILAZAD (U-74389) (1997) (0)
Methods for the study of the functions of the blood-brain barrier (1990) (0)
Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system. (1997) (0)
Building vascular roadmaps: A novel toolset for visualizing and annotating whole mouse brain vasculature (2020) (0)
Editorial Board (2011) (0)
Disease states and the blood-brain barrier related to peptides (1990) (0)
INTERACTION BETWEEN OBESITY, BRAIN HDL, AND APOE4 GENOTYPE IN CEREBRAL AMYLOIDOSIS (2019) (0)
385 A Cell Resolution Atlas of the Human Cerebrovasculature Reveals Angiogenic and Inflammatory Cell Programs in Arteriovenous Malformations (2023) (0)
A lymphatic waste-disposal system implicated in Alzheimer’s disease (2018) (0)
INDEPENDENT OF CSF AMYLOID/TAU LEVELS, HIGHER (NORMAL) DIASTOLIC BLOOD PRESSURE IN COGNITIVELY HEALTHY SENIORS ASSOCIATES WITH BETTER (NORMAL) EXECUTIVE FUNCTION AND WITH LESSER (NORMAL) MEMORY (2019) (0)
PERICYTE CONTRACTILITY BY OPTOGENETICS REGULATES CAPILLARY DIAMETER AND BLOOD FLOW (2019) (0)
Abstract WP90: Activate Protein C Analog Protects Ischemic Injury of Subcortical White Matter in Mice (2018) (0)
Vascular Endothelial Growth Factor Expression, Vascular Volume, and Capillary Permeability in Human Brain Tumors (1999) (0)
Reactive Oxygen Species in Reoxygenation Injury of Rat Brain Capillary Endothelial Cells (1998) (0)
NEUROINFLAMMATION IN ALZHEIMER’S DISEASE: TNF-α IS ASSOCIATED WITH ALTERED FUNCTIONAL CONNECTIVITY AMONG REWARD NETWORKS (2018) (0)
RELATIONSHIP BETWEEN CSF Aβ42 LEVELS AND HIPPOCAMPAL SUBREGION VOLUMES (2019) (0)
Advances in restorative neurosurgery: Endovascular delivery and fate determination of transplanted stem cells (2004) (0)
On the intersection between systemic infection, brain vascular dysfunction and dementia. (2021) (0)
Key Points * R 41 Q and R 46 Q point mutations in PAR 1 in mice enabled studies of APC ’ s in vivo mechanism of action in lethal sepsis and ischemic stroke (2018) (0)
Anticonvulsant Effects of Phencyclidine and PCP-like Drugs on Audiogenic Seizures Induced by Metaphit in Mice (1992) (0)
PYRAMIDAL SIGNS IN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2018) (0)
A NOVEL ASSAY FOR A BIOMARKER OF PERICYTE INJURY IN HUMAN CEREBROSPINAL FLUID (2019) (0)
Opening of the Blood—Brain Barrier to D-Mannitol Induced by Sensorimotor Cortical Lesions in the Anaesthetized Guinea-pig (1992) (0)
Transport of Some Precursors of Nucleotides and Some Vitamins (1993) (0)
Subiculum fiber degeneration within the fornix white matter tract in 5xFAD mice (2022) (0)
Analog Protects From Ischemic Stroke and Extends the Therapeutic Window of Tissue-Type Plasminogen Activator in Aged Female Mice and Hypertensive Rats (0)
583 Anti-amyloidogenic functions of the blood-brain barrier: Role of Gp330/megalin, and exclusion of apolipoproteins E3 and E4 (1996) (0)
The uptake of dopamine by the caudate nucleus of perfused guinea pig brain (1994) (0)
A Review of Translational Magnetic Resonance Imaging in Human and Rodent Experimental Models of Small Vessel Disease (2020) (0)
3K3A-Activated Protein C Variant Does Not Interfere With the Plasma Clot Lysis Activity of Tenecteplase (2020) (0)
Anti-TNF-alpha Antibody Reverses Experimental and Endotoxin Augmented Focal Ischemic Brain Injury: 793 (1997) (0)
Corrigendum: Acute ablation of cortical pericytes leads to rapid neurovascular uncoupling (2022) (0)
Abstract TMP27: Par1 Mediates Protective Effect of 3K3K-APC After White Matter Stroke in Mice (2020) (0)
ID: 330 Neuroprotective mechanisms of activated protein C (2006) (0)
Lens transport of ascorbic acid in guinea pigs, normal, galactose-fed and with congenital cataract (1996) (0)
Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism (2018) (0)
P3-326 Dysregulation in serum response factor and myocardin in Alzheimer's cerebral arterial system (2004) (0)
2313 Characterization of the host pericyte role in glioblastoma angiogenesis (2018) (0)
Experimental Models in the Study of the Pathology of the Blood-Brain Barrier (1993) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Berislav V. Zloković?

Berislav V. Zloković is affiliated with the following schools:

University of Southern California
University of Colorado
University of Rochester